Company
Bristol Myers Squibb
1,725 Legal Matters
79
864
782

Bristol Myers Squibb Company IP News and Updates

Mikele Bicolli
Top 10 Pharmaceuticals Losing Exclusivity in the US in 2024
Mikele Bicolli
Mar 11, 2024
As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and the subsequent...
Read More
Pedram Sameni
Patexia Insight 192: Top Brand and Generic Companies in ANDA 2023
Pedram Sameni
Nov 9, 2023
In August, our much-anticipated fourth annual ANDA Litigation Intelligence Report made its entrance into the world of pharmaceutical litigation. This...
Read More
Pedram Sameni
Patexia Insight 153: Top ANDA Firms of 2022
Pedram Sameni
Sep 29, 2022
Last August, we published our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape and focused...
Read More
Pedram Sameni
Patexia Insight 151: ANDA Litigators Who Moved in the Last 12 Months
Pedram Sameni
Sep 15, 2022
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by...
Read More
scott eads
Fresh From the Bench: Latest Federal Circuit Court Cases
scott eads
Feb 12, 2019
CASE OF THE WEEK Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC, Appeal No. 2017-2508 (Fed. Cir. Feb. 6, 2019)...
Read More
Knobbe Martens
MOMENTA PHARMACEUTICALS, INC. v. BRISTOL-MYERS SQUIBB COMPANY
Knobbe Martens
Feb 8, 2019
Federal Circuit Summary Before Newman, Dyk, and Chen.  Appeal from the Patent Trial and Appeal Board. Summary: An injury-in-fact is...
Read More
Showing 1-6 of 6 news found